Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
World Journal of Gastrointestinal Surgery|April 10, 2023
Current trends in perioperative treatment of resectable gastric cancerİbrahim Yıldız, Leyla Özer, Elif Şenocak Taşçı, et al.
American Journal of Medical Genetics. Part A|August 8, 2022
A novel SLC35D1 variant causing milder phenotype of Schneckenbecken dysplasia in a large pedigreeLeyla Özer, Suleyman Aktuna, Evrim Unsal, et al.
Frontiers in Oncology|October 20, 2025
Next-generation sequencing-based genomic profiling of advanced soft tissue and bone sarcomasYasemin Gündoğdu, Elif Şenocak Taşçı, Leyla Özer, et al.
Molecular Cytogenetics|November 24, 2015
Recombinant chromosome with partial 14 q trisomy due to maternal pericentric inversionHande Küçük Kurtulgan, Leyla Özer, Malik Ejder Yıldırım, et al.
Balkan Medical Journal|November 1, 2022
Intramural Component of Venous, Lymphatic, and Perineural Invasion in Colon Cancer: A Threat or an Illusion?Leyla Özer, Elif Şenocak Taşçı, Arda Ulaş Mutlu, et al.
Journal of Clinical Research in Pediatric Endocrinology|April 18, 2019
Novel Mutations in Obesity-related Genes in Turkish Children with Non-syndromic Early Onset Severe Obesity: A Multicentre StudyAyşehan Akıncı, Doğa Türkkahraman, İbrahim Tekedereli, et al.
Targeted Oncology|September 24, 2024
Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective TrialFeride Yılmaz, Serkan Yaşar, Nil Molinas Mandel, et al.
Cancers|September 28, 2024
Total Neoadjuvant Therapy Versus Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: A Multi-Institutional Real-World StudyElif Şenocak Taşçı, Arda Ulaş Mutlu, Onur Saylık, et al.
Expert Opinion on Pharmacotherapy|April 3, 2024
Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) studyElif Şenocak Taşçı, Yasin Kutlu, Ömer Fatih Ölmez, et al.
BMC Cancer|January 3, 2024
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancerElif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, et al.
Pageof 3